Demand for lentiviral vectors will continue to outstrip supply until the industry has access to more efficient, purpose-built manufacturing and bioprocessing technologies. The warning comes from ...
CAMBRIDGE, England--(BUSINESS WIRE)--Astrea Bioseparations (“Astrea Bio”), a leading provider of novel purification and separation tools supporting the development of next-generation therapeutics, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback